Literature DB >> 6276305

Delayed hypersensitivity to herpes simplex virus: murine model.

R D Schrier, L I Pizer, J W Moorhead.   

Abstract

Cell-mediated immunity has been shown to be clinically important in recovery from herpes simplex virus (HSV) infections. To investigate the role of delayed hypersensitivity (DH) in immunity and protection against HSV, we developed a murine model using the ear-swelling assay. Mice were infected subcutaneously with HSV-1 and ear-challenged, and the swelling was quantified. Significant ear swelling was detected by 3 to 4 days postinfection and peaked at 6 days. The kinetics of development of ear swelling were typical of DH: maximal swelling occurred 24 h post challenge and was diminished by 48 h, and the cellular infiltrate was predominantly mononuclear. Four-hour swelling, indicative of antibody-mediated, immediate-type hypersensitivity, was not detected until 15 days post immunization. The DH response was virus specific and could be transferred to normal recipients with lymph node T cells, but not with B cells or immune serum. This system will provide a useful model for evaluating the protective role of DH in HSV infection and for studying the specificity and interaction of T cells which mediate the response.

Entities:  

Mesh:

Year:  1982        PMID: 6276305      PMCID: PMC351078          DOI: 10.1128/iai.35.2.566-571.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Immune control of herpes simplex virus infections.

Authors:  F A Ennis; M Wells
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 4.  Herpes simplex infections in hematologic malignancies.

Authors:  S A Muller; E C Herrmann; R K Winkelmann
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

5.  Fatal disseminated herpesvirus hominis type 2 infection in an adult with associated thymic dysplasia.

Authors:  A L Sutton; E M Smithwick; S J Seligman; D S Kim
Journal:  Am J Med       Date:  1974-04       Impact factor: 4.965

Review 6.  Infectious complications of neoplastic disease.

Authors:  D Armstrong; L S Young; R D Meyer; A H Blevins
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

7.  Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients.

Authors:  E S Spencer; H K Andersen
Journal:  Br Med J       Date:  1970-08-01

8.  Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.

Authors:  E S Golub
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

9.  Anti-immunoglobulin stimulation of murine lymphocytes. II. Identification of cell surface target molecules and requirements for cross-linkage.

Authors:  H L Weiner; J W Moorhead; K Yamaga; R T Kubo
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  Genetic relatedness of type 1 and type 2 herpes simplex viruses.

Authors:  E Kieff; B Hoyer; S Bachenheimer; B Roizman
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

View more
  5 in total

1.  Different forms of membrane-associated herpes simplex virus glycoproteins induce functionally distinct subsets of herpes simplex virus-specific suppressor T cells.

Authors:  G Y Ishioka; L I Pizer; J W Moorhead
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

2.  Role of suppressor T cells in herpes simplex virus-induced immune deviation.

Authors:  J A Whittum; J Y Niederkorn; J P McCulley; J W Streilein
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

3.  Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen.

Authors:  Terrence M Tumpey; Robin Fenton; Sara Molesworth-Kenyon; John E Oakes; Robert N Lausch
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.

Authors:  H S Larsen; M F Feng; D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

5.  Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells.

Authors:  R D Schrier; L I Pizer; J W Moorhead
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.